Case report: posterior reversible encephalopathy syndrome, an adverse effect of lenvatinib and pembrolizumab combination therapy, in a patient with advanced endometrial cancer

HIGHLIGHTS

• who: Yuki Matsuura from the University of Bologna, Italy have published the article: Case report: Posterior reversible encephalopathy syndrome, an adverse effect of lenvatinib and pembrolizumab combination therapy, in a patient with advanced endometrial cancer, in the Journal: (JOURNAL)

SUMMARY

Endometrial cancer is one of the most common gynecologic malignancies, and its incidence has increased rapidly. Adenomyosis, a condition in which ectopic endometrial glands and stroma develop in the myometrium, can increase the risk of endometrial cancer development, similar to leiomyomas or polycystic ovary syndrome. Adenomyosis and endometrial cancer have similar traits: a . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.